North America Infusion Devices Market

The North America infusion devices market size is projected to reach US$ 9,116.47 million by 2031 from US$ 5,494.15 million in 2023. The market is expected to register a CAGR of 6.5% during 2023-2031.

According to the US Census Bureau, the number of Americans aged 65 and above is expected to rise from 58 million in 2022 to 82 million by 2050, which is a 47% increase. Additionally, the share of the total population for the 65-and-older age group is projected to rise from 17% to 23%. According to Statistics Canada, in 2022, almost ~18.8% of Canadians were aged 65 years. Almost 20% of the Canadian population is aged 65 years and above. Furthermore, population projections suggest that 21% to 29% of Canadians could be aged 65 or above by 2068.

A few key benefits of infusion therapy administered in senior populations are listed below.

• Rehydration and electrolyte balance: Dehydration can be a higher risk for seniors due to factors such as decreased thirst, certain medications, and changes in kidney function. IV fluids can help seniors maintain the necessary hydration and electrolyte levels for overall health.
• Nutrition support and improvement: Aging makes it harder for human bodies to consume the right nutrients, increasing the risk of chronic illnesses. Infusion therapy provides a direct way for seniors to get essential minerals, vitamins, and amino acids efficiently.
• Immune function reinforcement: Immune systems of elderly people may need extra support, as they are more vulnerable to infections. Infusion therapy can deliver immune-boosting nutrients such as vitamin C, zinc, and glutathione directly to the body.
• Pain management: Many seniors deal with chronic pain daily, affecting their quality of life. Infusion therapy can quickly and effectively manage pain by delivering medication directly into the bloodstream, providing relief and reducing inflammation.

Thus, the increasing geriatric population drives the demand for infusion devices across North America. 

Strategic Initiatives by Market Players

• In April 2024, Mackenzie Health launched a technology in Canada that allows for two-way information flow between an intravenous (IV) medication pump and a patient's electronic medical record. The technology, known as BD Alaris EMR Interoperability, eliminates the need for healthcare professionals to manually program pumps. It sends infusion safety information back to Epic EMR, reducing the risk of administration errors and providing an accurate infusion record in the EMR.
• In November 2022, Medtronic plc announced the launch of Medtronic Extended infusion set in the US. It is the first and only infusion set labeled for up to seven-day wear. An infusion set is tubing that delivers insulin from an insulin pump to the body and usually needs to be changed every two to three days.
• In May 2022, Fresenius Kabi acquired Ivenix and its advanced infusion pump technology, expanding its portfolio of advanced infusion pumps and solutions for healthcare professionals to address healthcare needs across the care continuum. Fresenius Kabi also announced that it has rapidly expanded its infusion therapy portfolio in the US, obtaining FDA approvals for multiple IV solutions in anticipation of qualifying its North Carolina manufacturing site to supply the US customers with IV solutions.
• In March 2022, Fresenius Kabi received 510(k) regulatory clearance from the FDA for its wireless Agilia Connect Infusion System. The system includes the Agilia Volumetric Pump and the Agilia Syringe Pump with Vigilant Software Suite-Vigilant Master Med technology. Both pumps are the first to be cleared following TIR101 standards, which were developed by the Association for the Advancement of Medical Instrumentation (AAMI) in 2021.

An upsurge in the number of product approvals, launches, and strategic collaborations is likely to create lucrative opportunities for the infusion devices market in the future. 

End User-Based Insights

North America Infusion Devices Strategic Insights

Strategic insights for the North America Infusion Devices provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

North America Infusion Devices Report Scope

North America Infusion Devices Regional Insights

The geographic scope of the North America Infusion Devices refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.